Share on LinkedInShare on LinkedIn

ARTICLE · 13 AUGUST 2018

Patent Backlog In Brazil: Slow, But Welcome, Progress

In 2017, the number of pending patent applications awaiting a final decision was reduced by 7.6%.

BrazilIntellectual Property

In 2017, the number of pending patent applications awaiting a final decision was reduced by 7.6%. The backlog reduction was the result of a combination of factors, including a 25% increase in the Brazilian Patent and Trademark Office's (INPI) staff, optimisation of internal procedures, and improvements in the INPI's electronic systems in particular. These proposed measures were promising, but 2017 still closed with worrying backlog statistics.

The overall average consists of 10.23 years from filing until grant, but the decision time for applications in the pharma field reaches a disappointing average of 13.63 years, behind only telecoms applications. The backlog was significantly worse in the past for pharmaceutical cases, due to the double patentability examination carried out by the INPI and the Brazilian National Health Surveillance Agency (ANVISA).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from